Track record · closed signal

Novo Nordisk A/S (NVO) — closed signal from April 10, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on July 9, 2026.

Predicted vs. what happened

NVO price · publication thesis → realized outcomesplit-adjusted
$38.10 Published $41.14 Target $48.88 Window close $50.90 Peak
$36.80 – $38.20Entry zone — fair-value band
$38.10Published — price the day we called it
$41.14Target — the price the thesis aimed for
$50.90Peak — highest point inside the window, not a realized return
$48.88Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 6 days.

Peak price
$50.90
peak on July 2, 2026 — not a realized return
Peak gain
+33.6%
peak, from the publication price
Window close
$48.88
end-of-window price, context only
Days to target
6
Window
April 10, 2026 – July 9, 2026

The thesis — published April 10, 2026

Predicted growth
+8%
over the measurement window
Target price
$41.14
the price the thesis aimed for
Entry zone
$36.80 – $38.20
the fair-value band we waited for
Price at publication
$38.10
published April 10, 2026
Confidence
64%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Novo Nordisk is less attractive over the next few months because the setup is messier than other healthcare ideas. Changes to Wegovy dosing and pricing keep the drug important, but strong competition from Lilly's oral obesity pill and weaker growth momentum make the near-term rebound less convincing.

Primary drivers

  • Higher-dose Wegovy and pricing tweaks keep the product line relevant
  • Profitability remains strong and supports the core business
  • Lilly's oral obesity pill increases short-term competitive pressure
  • Recent price bounce is weaker without clear earnings momentum

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All NVO signals